---
document_datetime: 2023-09-21 18:22:21
document_pages: 5
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/preotact-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: preotact-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 3.5500075
conversion_datetime: 2025-12-28 11:07:21.07912
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Preotact

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                   | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on no   | Product Information affected 3   | Summary   |
|----------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|------------------------------------------------|----------------------------------|-----------|
| IG/0421              | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location product | 21/03/2014                          | n/a                                            |                                  |           |
| II/0023/G            | This was an application for a group of variations. Changes to the testing arrangements for active substance and finished product.                                       | 20/03/2014                          | n/a                                            |                                  |           |

Medicinal product no longer authorised

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|         | B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure   |                    |                   |                        | authorised                                                              |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------|-------------------|------------------------|-------------------------------------------------------------------------|
| T/0022  | Transfer of Market Authorisation from Nycomed Danmark ApS to NPS Pharma Holdings Limited. Transfer of Marketing Authorisation                                                                                                                                                                                                                                                   | 24/10/2013         | 29/11/2013 longer | SmPC, Labelling and PL | Transfer of the Marketing Authorisation to NPS Pharma Holdings Limited. |
| IA/0021 | B.II.e.5.b - Change in pack size of the finished product - Deletion of a pack size(s)                                                                                                                                                                                                                                                                                           | 27/06/2013         | 29/11/2013 no     | SmPC, Labelling and PL |                                                                         |
| IG/0293 | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                  | 23/04/2013 product | n/a               |                        |                                                                         |
| IG/0219 | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                  | 25/09/2012         | n/a               |                        |                                                                         |
| II/0017 | To register a new presentation: cartridge in a pre-filled pen. B.IV.1.c - Change of a measuring or administration device - Addition or replacement of a device which is an integrated part of the primary packaging Medicinal                                                                                                                                                   | 15/03/2012         | 20/04/2012        | SmPC, Labelling and PL |                                                                         |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| IB/0018   | B.I.d.1.b.3 - Stability of AS - Change in the storage conditions - Change in storage conditions of the AS                        | 29/11/2011         | n/a           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------|--------------------|---------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0016   | C.I.9.c - Changes to an existing pharmacovigilance system as described in the DDPS - Change of the back-up procedure of the QPPV | 24/06/2011         | n/a           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| R/0015    | Renewal of the marketing authorisation. Medicinal                                                                                | 17/02/2011 product | 14/04/2011 no | SmPC and PL Based on the CHMP review of the available information and on the basis of a re-evaluation of the benefit/risk balance, the CHMP is of the opinion that the quality, safety and efficacy of this medicinal product continues to be adequately and sufficiently demonstrated and therefore considered that the benefit/risk profile of Preotact continues to be favourable. The CHMP is of the opinion that the renewal can be granted with unlimited validity. The MAH will switch to a 3-yearly PSUR cycle. During the renewal procedure, changes were made to the Product Information to bring it in line with the current EMEA/QRD template, SmPC guideline and other relevant guideline(s), which were reviewed by QRD and accepted by the CHMP. Currently there are two parathyroid hormone products marketed: Preotact (parathyroid hormone) and Forsteo (teriparatide). Both have identical mechanisms of action: stimulation of bone formation by direct effects on bone forming cells (osteoblasts) and indirectly increases the intestinal absorption of calcium and increases the tubular reabsorption of calcium and excretion of phosphate by the kidney. In section 4.3 of the Forsteo SmPC, there is a contraindication in patients with skeletal malignancies or bone metastases. So far, Preotact has not been contraindicated in these patients and therefore, for longer authorised |

<div style=\"page-break-after: always\"></div>

| IA/0014   | C.I.9.a - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the QPPV                                                                                                                                                            | 27/10/2010   | consistency, the Preotact product updated in line with Forsteo procedure. n/a Annex II authorised   |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-----------------------------------------------------------------------------------------------------|
| II/0009   | Changes to the manufacturing process of the active substance B.I.a.2.c - Changes in the manufacturing process of the AS - The change refers to a [-] substance in the manufacture of a biological/immunological medicinal product and is not related to a protocol | 23/09/2010   | 04/10/2010                                                                                          |
| IB/0010   | B.II.e.3.b - Change in test procedure for the immediate packaging of the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                  | 21/07/2010   | n/a no longer                                                                                       |
| IA/0011   | B.II.b.z - Change in manufacture of the Finished Product - Other variation                                                                                                                                                                                         | 16/07/2010   | n/a                                                                                                 |
| IA/0012   | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure product                                                                                                                                               | 12/07/2010   | n/a                                                                                                 |
| II/0008   | New site for the control of the drug substance and drug product 01_Change in or addition of manufacturing site(s) for part or all of the manufacturing process Medicinal                                                                                           | 18/03/2010   | 24/03/2010                                                                                          |

<div style=\"page-break-after: always\"></div>

| IB/0007   | IB_17_b_Change in the storage conditions for the active substance                                                                   | 31/03/2009   | n/a        |                                                                                                                                                                              |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0006   | Changes to release testing of PTH reference standard Change(s) to the test method(s) and/or specifications for the active substance | 25/09/2008   | 02/10/2008 | authorised                                                                                                                                                                   |
| II/0005   | Change(s) to the manufacturing process for the active substance                                                                     | 24/04/2008   | 29/04/2008 |                                                                                                                                                                              |
| N/0004    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                    | 27/11/2007   | n/a longer |                                                                                                                                                                              |
| II/0003   | Change(s) to the manufacturing process for the active substance                                                                     | 24/05/2007   | 24/07/2007 | The CHMP adopted a positive opinion on the replacement of the facility for the manufacture of the drug substance and the consequential scale-up of the fermentation process. |
| IB/0002   | IB_17_b_Change in the storage conditions for the active substance                                                                   | 10/04/2007   | n/a no     |                                                                                                                                                                              |
| II/0001   | Quality changes                                                                                                                     | 22/03/2007   | 29/03/2007 |                                                                                                                                                                              |

Medicinal product no longer authorised